BioNTech SE
BNTX
$89.27
-$0.04-0.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.39% | -26.46% | 29.76% | -786.05% | -171.78% |
| Total Depreciation and Amortization | 23.80% | 19.56% | -21.22% | -15.98% | -14.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 284.46% | 81.99% | -116.59% | 27.41% | 61.18% |
| Change in Net Operating Assets | -49.57% | -91.70% | -135.57% | -89.97% | -78.44% |
| Cash from Operations | 193.17% | -114.59% | -157.75% | -104.28% | -96.40% |
| Capital Expenditure | 36.19% | 40.68% | 24.21% | -4.31% | -14.56% |
| Sale of Property, Plant, and Equipment | 301.35% | 859.51% | 907.76% | -- | -- |
| Cash Acquisitions | -- | -- | 77.47% | 77.47% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.36% | 119.61% | 132.28% | 122.38% | 71.51% |
| Cash from Investing | -32.79% | 113.82% | 124.69% | 116.70% | 69.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.49% | 9.82% | 19.27% | -33.42% | -13.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.42% | 8.70% | 88.05% | 89.67% | 94.12% |
| Foreign Exchange rate Adjustments | -289.94% | 88.51% | 106.83% | -137.46% | 215.44% |
| Miscellaneous Cash Flow Adjustments | 136.56% | -109.51% | -84.54% | -44.69% | -98.06% |
| Net Change in Cash | -18.60% | 111.43% | 96.61% | 137.21% | 11.32% |